Originally developed in Australia in the 1990s, it was designed to harness the fat-burning properties of growth hormone without triggering its broader hormonal effects
Research shows it enhances fibroblast migration to injury sites through the FAK-paxillin pathway, improves collagen fiber organization and cross-linking, promotes angiogenesis to improve nutrient delivery, and reduces inflammatory mediators while preserving beneficial healing signals
Accurate potency is vital to ensure therapeutic efficacy and to avoid underdosing or overdosing, which could lead to inadequate treatment or adverse effects
Semaglutide, also known as Ozempic and Wegovy, is one of the leading medications for sustainable weight loss, offering meaningful results without requiring extreme diets or deprivation
Most reported protocols settle at 100 mg as the maintenance level